nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—LTK—mouth—Behcet's disease	0.00987	0.0177	CbGeAlD
Vandetanib—FLT4—endothelium—Behcet's disease	0.00732	0.0131	CbGeAlD
Vandetanib—RIPK2—endothelium—Behcet's disease	0.00728	0.0131	CbGeAlD
Vandetanib—TEK—artery—Behcet's disease	0.00697	0.0125	CbGeAlD
Vandetanib—FLT4—blood vessel—Behcet's disease	0.00675	0.0121	CbGeAlD
Vandetanib—RIPK2—blood vessel—Behcet's disease	0.00672	0.0121	CbGeAlD
Vandetanib—SRC—artery—Behcet's disease	0.00619	0.0111	CbGeAlD
Vandetanib—EPHA8—eye—Behcet's disease	0.00602	0.0108	CbGeAlD
Vandetanib—TEK—endothelium—Behcet's disease	0.00589	0.0106	CbGeAlD
Vandetanib—KDR—artery—Behcet's disease	0.0057	0.0102	CbGeAlD
Vandetanib—TEK—blood vessel—Behcet's disease	0.00543	0.00975	CbGeAlD
Vandetanib—ERBB3—mouth—Behcet's disease	0.00538	0.00965	CbGeAlD
Vandetanib—PTK6—skin of body—Behcet's disease	0.00523	0.00939	CbGeAlD
Vandetanib—SRC—endothelium—Behcet's disease	0.00523	0.00939	CbGeAlD
Vandetanib—SRC—blood vessel—Behcet's disease	0.00483	0.00866	CbGeAlD
Vandetanib—KDR—endothelium—Behcet's disease	0.00481	0.00864	CbGeAlD
Vandetanib—TYRO3—brainstem—Behcet's disease	0.00478	0.00858	CbGeAlD
Vandetanib—PTK6—mammalian vulva—Behcet's disease	0.00477	0.00857	CbGeAlD
Vandetanib—EPHA5—eye—Behcet's disease	0.00465	0.00835	CbGeAlD
Vandetanib—EPHA5—retina—Behcet's disease	0.00461	0.00828	CbGeAlD
Vandetanib—KDR—blood vessel—Behcet's disease	0.00444	0.00797	CbGeAlD
Vandetanib—TYRO3—skin of body—Behcet's disease	0.00405	0.00727	CbGeAlD
Vandetanib—STK35—brainstem—Behcet's disease	0.00398	0.00715	CbGeAlD
Vandetanib—PDGFRB—blood vessel—Behcet's disease	0.00384	0.0069	CbGeAlD
Vandetanib—FLT4—eye—Behcet's disease	0.00359	0.00645	CbGeAlD
Vandetanib—RIPK2—eye—Behcet's disease	0.00357	0.00641	CbGeAlD
Vandetanib—RIPK2—retina—Behcet's disease	0.00354	0.00636	CbGeAlD
Vandetanib—STK35—skin of body—Behcet's disease	0.00337	0.00605	CbGeAlD
Vandetanib—EPHA5—medulla oblongata—Behcet's disease	0.00333	0.00598	CbGeAlD
Vandetanib—EPHA8—nervous system—Behcet's disease	0.00324	0.00581	CbGeAlD
Vandetanib—MKNK1—eye—Behcet's disease	0.00321	0.00576	CbGeAlD
Vandetanib—MKNK1—retina—Behcet's disease	0.00318	0.00571	CbGeAlD
Vandetanib—AXL—eye—Behcet's disease	0.00316	0.00567	CbGeAlD
Vandetanib—AXL—retina—Behcet's disease	0.00313	0.00562	CbGeAlD
Vandetanib—EPHA8—central nervous system—Behcet's disease	0.00312	0.00559	CbGeAlD
Vandetanib—RIPK2—skin of body—Behcet's disease	0.00311	0.00558	CbGeAlD
Vandetanib—FMO3—eye—Behcet's disease	0.00306	0.0055	CbGeAlD
Vandetanib—EPHA5—midbrain—Behcet's disease	0.00305	0.00547	CbGeAlD
Vandetanib—FYN—brainstem—Behcet's disease	0.00304	0.00545	CbGeAlD
Vandetanib—ERBB3—skin of body—Behcet's disease	0.00298	0.00534	CbGeAlD
Vandetanib—TYRO3—spinal cord—Behcet's disease	0.00297	0.00533	CbGeAlD
Vandetanib—EPHA5—spinal cord—Behcet's disease	0.00297	0.00533	CbGeAlD
Vandetanib—STK35—cardiac atrium—Behcet's disease	0.00295	0.00529	CbGeAlD
Vandetanib—EGFR—mammalian vulva—Behcet's disease	0.00293	0.00525	CbGeAlD
Vandetanib—VEGFA—mammalian vulva—Behcet's disease	0.00283	0.00508	CbGeAlD
Vandetanib—FMO1—mammalian vulva—Behcet's disease	0.00281	0.00505	CbGeAlD
Vandetanib—IRAK4—mammalian vulva—Behcet's disease	0.00277	0.00497	CbGeAlD
Vandetanib—AXL—skin of body—Behcet's disease	0.00275	0.00493	CbGeAlD
Vandetanib—RIPK2—cardiac atrium—Behcet's disease	0.00272	0.00487	CbGeAlD
Vandetanib—VEGFA—cardiac atrium—Behcet's disease	0.00271	0.00486	CbGeAlD
Vandetanib—EPHA6—nervous system—Behcet's disease	0.0027	0.00485	CbGeAlD
Vandetanib—YES1—eye—Behcet's disease	0.00267	0.00479	CbGeAlD
Vandetanib—YES1—retina—Behcet's disease	0.00265	0.00475	CbGeAlD
Vandetanib—EPHA6—central nervous system—Behcet's disease	0.0026	0.00466	CbGeAlD
Vandetanib—LTK—brain—Behcet's disease	0.00258	0.00463	CbGeAlD
Vandetanib—FYN—skin of body—Behcet's disease	0.00257	0.00462	CbGeAlD
Vandetanib—SRC—eye—Behcet's disease	0.00257	0.00461	CbGeAlD
Vandetanib—RIPK2—medulla oblongata—Behcet's disease	0.00256	0.00459	CbGeAlD
Vandetanib—MKNK1—mammalian vulva—Behcet's disease	0.00255	0.00457	CbGeAlD
Vandetanib—SRC—retina—Behcet's disease	0.00254	0.00457	CbGeAlD
Vandetanib—STK35—midbrain—Behcet's disease	0.00254	0.00455	CbGeAlD
Vandetanib—LCK—mammalian vulva—Behcet's disease	0.00252	0.00452	CbGeAlD
Vandetanib—FGR—mammalian vulva—Behcet's disease	0.00252	0.00452	CbGeAlD
Vandetanib—AXL—mammalian vulva—Behcet's disease	0.00251	0.0045	CbGeAlD
Vandetanib—TYRO3—nervous system—Behcet's disease	0.0025	0.00449	CbGeAlD
Vandetanib—EPHA5—nervous system—Behcet's disease	0.0025	0.00449	CbGeAlD
Vandetanib—IRAK4—medulla oblongata—Behcet's disease	0.0025	0.00449	CbGeAlD
Vandetanib—LYN—nervous system—Behcet's disease	0.00249	0.00447	CbGeAlD
Vandetanib—EPHA8—brain—Behcet's disease	0.00247	0.00444	CbGeAlD
Vandetanib—BMPR1B—nervous system—Behcet's disease	0.00245	0.0044	CbGeAlD
Vandetanib—MAP3K19—nervous system—Behcet's disease	0.00245	0.0044	CbGeAlD
Vandetanib—MKNK1—cardiac atrium—Behcet's disease	0.00244	0.00438	CbGeAlD
Vandetanib—FMO3—mammalian vulva—Behcet's disease	0.00243	0.00436	CbGeAlD
Vandetanib—MAP2K5—brainstem—Behcet's disease	0.00243	0.00435	CbGeAlD
Vandetanib—SLK—mammalian vulva—Behcet's disease	0.00241	0.00433	CbGeAlD
Vandetanib—TYRO3—central nervous system—Behcet's disease	0.00241	0.00433	CbGeAlD
Vandetanib—EPHA5—central nervous system—Behcet's disease	0.00241	0.00433	CbGeAlD
Vandetanib—EPHB6—skin of body—Behcet's disease	0.0024	0.00431	CbGeAlD
Vandetanib—AXL—cardiac atrium—Behcet's disease	0.0024	0.00431	CbGeAlD
Vandetanib—LYN—central nervous system—Behcet's disease	0.0024	0.0043	CbGeAlD
Vandetanib—BMPR1B—central nervous system—Behcet's disease	0.00236	0.00424	CbGeAlD
Vandetanib—MAP3K19—central nervous system—Behcet's disease	0.00236	0.00424	CbGeAlD
Vandetanib—KDR—eye—Behcet's disease	0.00236	0.00424	CbGeAlD
Vandetanib—FYN—mammalian vulva—Behcet's disease	0.00235	0.00421	CbGeAlD
Vandetanib—KDR—retina—Behcet's disease	0.00234	0.0042	CbGeAlD
Vandetanib—RIPK2—midbrain—Behcet's disease	0.00234	0.0042	CbGeAlD
Vandetanib—SLK—cardiac atrium—Behcet's disease	0.00231	0.00415	CbGeAlD
Vandetanib—MKNK1—medulla oblongata—Behcet's disease	0.0023	0.00413	CbGeAlD
Vandetanib—MAP4K5—mammalian vulva—Behcet's disease	0.00229	0.00412	CbGeAlD
Vandetanib—RIPK2—spinal cord—Behcet's disease	0.00228	0.0041	CbGeAlD
Vandetanib—VEGFA—spinal cord—Behcet's disease	0.00228	0.00409	CbGeAlD
Vandetanib—RET—medulla oblongata—Behcet's disease	0.00227	0.00408	CbGeAlD
Vandetanib—AXL—medulla oblongata—Behcet's disease	0.00226	0.00406	CbGeAlD
Vandetanib—FYN—cardiac atrium—Behcet's disease	0.00225	0.00403	CbGeAlD
Vandetanib—ERBB3—midbrain—Behcet's disease	0.00224	0.00402	CbGeAlD
Vandetanib—SRC—skin of body—Behcet's disease	0.00223	0.00401	CbGeAlD
Vandetanib—IRAK4—spinal cord—Behcet's disease	0.00223	0.004	CbGeAlD
Vandetanib—MAP4K5—cardiac atrium—Behcet's disease	0.0022	0.00394	CbGeAlD
Vandetanib—TEK—cardiac atrium—Behcet's disease	0.0022	0.00394	CbGeAlD
Vandetanib—EPHB6—mammalian vulva—Behcet's disease	0.00219	0.00393	CbGeAlD
Vandetanib—ERBB3—spinal cord—Behcet's disease	0.00219	0.00392	CbGeAlD
Vandetanib—SLK—medulla oblongata—Behcet's disease	0.00218	0.00391	CbGeAlD
Vandetanib—FYN—medulla oblongata—Behcet's disease	0.00212	0.0038	CbGeAlD
Vandetanib—YES1—mammalian vulva—Behcet's disease	0.00212	0.0038	CbGeAlD
Vandetanib—MKNK1—midbrain—Behcet's disease	0.0021	0.00377	CbGeAlD
Vandetanib—STK10—mammalian vulva—Behcet's disease	0.0021	0.00377	CbGeAlD
Vandetanib—EPHB6—cardiac atrium—Behcet's disease	0.0021	0.00377	CbGeAlD
Vandetanib—STK35—nervous system—Behcet's disease	0.00209	0.00374	CbGeAlD
Vandetanib—RET—midbrain—Behcet's disease	0.00208	0.00373	CbGeAlD
Vandetanib—TEK—medulla oblongata—Behcet's disease	0.00207	0.00372	CbGeAlD
Vandetanib—MAP4K5—medulla oblongata—Behcet's disease	0.00207	0.00372	CbGeAlD
Vandetanib—AXL—midbrain—Behcet's disease	0.00207	0.00371	CbGeAlD
Vandetanib—EPHA6—brain—Behcet's disease	0.00206	0.0037	CbGeAlD
Vandetanib—MKNK1—spinal cord—Behcet's disease	0.00205	0.00368	CbGeAlD
Vandetanib—PDGFRB—eye—Behcet's disease	0.00204	0.00367	CbGeAlD
Vandetanib—PLK4—brain—Behcet's disease	0.00204	0.00366	CbGeAlD
Vandetanib—YES1—cardiac atrium—Behcet's disease	0.00203	0.00364	CbGeAlD
Vandetanib—RET—spinal cord—Behcet's disease	0.00203	0.00364	CbGeAlD
Vandetanib—AXL—spinal cord—Behcet's disease	0.00202	0.00362	CbGeAlD
Vandetanib—STK35—central nervous system—Behcet's disease	0.00201	0.0036	CbGeAlD
Vandetanib—SLK—midbrain—Behcet's disease	0.00199	0.00357	CbGeAlD
Vandetanib—EPHB6—medulla oblongata—Behcet's disease	0.00198	0.00355	CbGeAlD
Vandetanib—SRC—cardiac atrium—Behcet's disease	0.00195	0.0035	CbGeAlD
Vandetanib—SLK—spinal cord—Behcet's disease	0.00194	0.00349	CbGeAlD
Vandetanib—FYN—midbrain—Behcet's disease	0.00194	0.00347	CbGeAlD
Vandetanib—EPHA5—brain—Behcet's disease	0.00191	0.00344	CbGeAlD
Vandetanib—TYRO3—brain—Behcet's disease	0.00191	0.00344	CbGeAlD
Vandetanib—YES1—medulla oblongata—Behcet's disease	0.00191	0.00343	CbGeAlD
Vandetanib—FMO1—nervous system—Behcet's disease	0.00191	0.00342	CbGeAlD
Vandetanib—LYN—brain—Behcet's disease	0.0019	0.00342	CbGeAlD
Vandetanib—MAP4K5—midbrain—Behcet's disease	0.00189	0.0034	CbGeAlD
Vandetanib—TEK—midbrain—Behcet's disease	0.00189	0.0034	CbGeAlD
Vandetanib—FYN—spinal cord—Behcet's disease	0.00189	0.00339	CbGeAlD
Vandetanib—IRAK4—nervous system—Behcet's disease	0.00188	0.00337	CbGeAlD
Vandetanib—MAP3K19—brain—Behcet's disease	0.00188	0.00337	CbGeAlD
Vandetanib—BMPR1B—brain—Behcet's disease	0.00188	0.00337	CbGeAlD
Vandetanib—MAP2K5—mammalian vulva—Behcet's disease	0.00187	0.00336	CbGeAlD
Vandetanib—KDR—mammalian vulva—Behcet's disease	0.00187	0.00336	CbGeAlD
Vandetanib—ABL1—brainstem—Behcet's disease	0.00187	0.00336	CbGeAlD
Vandetanib—MAP4K5—spinal cord—Behcet's disease	0.00185	0.00331	CbGeAlD
Vandetanib—TEK—spinal cord—Behcet's disease	0.00185	0.00331	CbGeAlD
Vandetanib—ERBB3—nervous system—Behcet's disease	0.00184	0.0033	CbGeAlD
Vandetanib—FMO1—central nervous system—Behcet's disease	0.00184	0.0033	CbGeAlD
Vandetanib—ABL1—eye—Behcet's disease	0.00182	0.00327	CbGeAlD
Vandetanib—IRAK4—central nervous system—Behcet's disease	0.00181	0.00325	CbGeAlD
Vandetanib—EPHB6—midbrain—Behcet's disease	0.00181	0.00325	CbGeAlD
Vandetanib—ABL1—retina—Behcet's disease	0.00181	0.00324	CbGeAlD
Vandetanib—MAP2K5—cardiac atrium—Behcet's disease	0.00179	0.00322	CbGeAlD
Vandetanib—KDR—cardiac atrium—Behcet's disease	0.00179	0.00322	CbGeAlD
Vandetanib—PDGFRB—skin of body—Behcet's disease	0.00178	0.00319	CbGeAlD
Vandetanib—ERBB3—central nervous system—Behcet's disease	0.00177	0.00318	CbGeAlD
Vandetanib—EPHB6—spinal cord—Behcet's disease	0.00176	0.00317	CbGeAlD
Vandetanib—YES1—midbrain—Behcet's disease	0.00175	0.00314	CbGeAlD
Vandetanib—MKNK1—nervous system—Behcet's disease	0.00173	0.0031	CbGeAlD
Vandetanib—FGR—nervous system—Behcet's disease	0.00171	0.00306	CbGeAlD
Vandetanib—RET—nervous system—Behcet's disease	0.00171	0.00306	CbGeAlD
Vandetanib—YES1—spinal cord—Behcet's disease	0.0017	0.00306	CbGeAlD
Vandetanib—AXL—nervous system—Behcet's disease	0.0017	0.00305	CbGeAlD
Vandetanib—MAP2K5—medulla oblongata—Behcet's disease	0.00169	0.00304	CbGeAlD
Vandetanib—KDR—medulla oblongata—Behcet's disease	0.00169	0.00304	CbGeAlD
Vandetanib—MKNK1—central nervous system—Behcet's disease	0.00166	0.00299	CbGeAlD
Vandetanib—FMO3—nervous system—Behcet's disease	0.00165	0.00296	CbGeAlD
Vandetanib—FGR—central nervous system—Behcet's disease	0.00164	0.00295	CbGeAlD
Vandetanib—RET—central nervous system—Behcet's disease	0.00164	0.00295	CbGeAlD
Vandetanib—SRC—spinal cord—Behcet's disease	0.00164	0.00294	CbGeAlD
Vandetanib—AXL—central nervous system—Behcet's disease	0.00164	0.00294	CbGeAlD
Vandetanib—PDGFRB—mammalian vulva—Behcet's disease	0.00162	0.00291	CbGeAlD
Vandetanib—STK35—brain—Behcet's disease	0.00159	0.00286	CbGeAlD
Vandetanib—FYN—nervous system—Behcet's disease	0.00159	0.00286	CbGeAlD
Vandetanib—FMO3—central nervous system—Behcet's disease	0.00159	0.00285	CbGeAlD
Vandetanib—ABL1—skin of body—Behcet's disease	0.00159	0.00285	CbGeAlD
Vandetanib—TEK—nervous system—Behcet's disease	0.00156	0.00279	CbGeAlD
Vandetanib—MAP4K5—nervous system—Behcet's disease	0.00156	0.00279	CbGeAlD
Vandetanib—ABL2—brain—Behcet's disease	0.00155	0.00279	CbGeAlD
Vandetanib—PDGFRB—cardiac atrium—Behcet's disease	0.00155	0.00279	CbGeAlD
Vandetanib—KDR—midbrain—Behcet's disease	0.00155	0.00278	CbGeAlD
Vandetanib—MAP2K5—midbrain—Behcet's disease	0.00155	0.00278	CbGeAlD
Vandetanib—FYN—central nervous system—Behcet's disease	0.00153	0.00275	CbGeAlD
Vandetanib—EGFR—brain—Behcet's disease	0.00152	0.00272	CbGeAlD
Vandetanib—MAP2K5—spinal cord—Behcet's disease	0.00151	0.00271	CbGeAlD
Vandetanib—KDR—spinal cord—Behcet's disease	0.00151	0.00271	CbGeAlD
Vandetanib—TEK—central nervous system—Behcet's disease	0.0015	0.00269	CbGeAlD
Vandetanib—MAP4K5—central nervous system—Behcet's disease	0.0015	0.00269	CbGeAlD
Vandetanib—EPHB6—nervous system—Behcet's disease	0.00149	0.00267	CbGeAlD
Vandetanib—FLT4—brain—Behcet's disease	0.00148	0.00265	CbGeAlD
Vandetanib—RIPK2—brain—Behcet's disease	0.00147	0.00264	CbGeAlD
Vandetanib—VEGFA—brain—Behcet's disease	0.00147	0.00263	CbGeAlD
Vandetanib—PDGFRB—medulla oblongata—Behcet's disease	0.00146	0.00263	CbGeAlD
Vandetanib—FMO1—brain—Behcet's disease	0.00146	0.00262	CbGeAlD
Vandetanib—ABL1—mammalian vulva—Behcet's disease	0.00145	0.00259	CbGeAlD
Vandetanib—YES1—nervous system—Behcet's disease	0.00144	0.00258	CbGeAlD
Vandetanib—IRAK4—brain—Behcet's disease	0.00144	0.00258	CbGeAlD
Vandetanib—EPHB6—central nervous system—Behcet's disease	0.00143	0.00257	CbGeAlD
Vandetanib—STK10—nervous system—Behcet's disease	0.00142	0.00255	CbGeAlD
Vandetanib—ERBB3—brain—Behcet's disease	0.00141	0.00253	CbGeAlD
Vandetanib—ABL1—cardiac atrium—Behcet's disease	0.00138	0.00248	CbGeAlD
Vandetanib—YES1—central nervous system—Behcet's disease	0.00138	0.00248	CbGeAlD
Vandetanib—SRC—nervous system—Behcet's disease	0.00138	0.00248	CbGeAlD
Vandetanib—STK10—central nervous system—Behcet's disease	0.00137	0.00246	CbGeAlD
Vandetanib—PDGFRB—midbrain—Behcet's disease	0.00134	0.0024	CbGeAlD
Vandetanib—SRC—central nervous system—Behcet's disease	0.00133	0.00239	CbGeAlD
Vandetanib—MKNK1—brain—Behcet's disease	0.00132	0.00237	CbGeAlD
Vandetanib—PDGFRB—spinal cord—Behcet's disease	0.00131	0.00234	CbGeAlD
Vandetanib—ABL1—medulla oblongata—Behcet's disease	0.00131	0.00234	CbGeAlD
Vandetanib—FGR—brain—Behcet's disease	0.00131	0.00234	CbGeAlD
Vandetanib—RET—brain—Behcet's disease	0.00131	0.00234	CbGeAlD
Vandetanib—AXL—brain—Behcet's disease	0.0013	0.00233	CbGeAlD
Vandetanib—KDR—nervous system—Behcet's disease	0.00127	0.00228	CbGeAlD
Vandetanib—MAP2K5—nervous system—Behcet's disease	0.00127	0.00228	CbGeAlD
Vandetanib—FMO3—brain—Behcet's disease	0.00126	0.00226	CbGeAlD
Vandetanib—SLK—brain—Behcet's disease	0.00125	0.00225	CbGeAlD
Vandetanib—ORM1—spinal cord—Behcet's disease	0.00122	0.0022	CbGeAlD
Vandetanib—KDR—central nervous system—Behcet's disease	0.00122	0.0022	CbGeAlD
Vandetanib—MAP2K5—central nervous system—Behcet's disease	0.00122	0.0022	CbGeAlD
Vandetanib—FYN—brain—Behcet's disease	0.00122	0.00218	CbGeAlD
Vandetanib—ABL1—midbrain—Behcet's disease	0.00119	0.00214	CbGeAlD
Vandetanib—TEK—brain—Behcet's disease	0.00119	0.00213	CbGeAlD
Vandetanib—MAP4K5—brain—Behcet's disease	0.00119	0.00213	CbGeAlD
Vandetanib—ABL1—spinal cord—Behcet's disease	0.00116	0.00209	CbGeAlD
Vandetanib—EPHB6—brain—Behcet's disease	0.00114	0.00204	CbGeAlD
Vandetanib—ABCC1—mammalian vulva—Behcet's disease	0.0011	0.00198	CbGeAlD
Vandetanib—PDGFRB—nervous system—Behcet's disease	0.0011	0.00197	CbGeAlD
Vandetanib—YES1—brain—Behcet's disease	0.0011	0.00197	CbGeAlD
Vandetanib—STK10—brain—Behcet's disease	0.00109	0.00195	CbGeAlD
Vandetanib—PDGFRB—central nervous system—Behcet's disease	0.00106	0.0019	CbGeAlD
Vandetanib—SRC—brain—Behcet's disease	0.00106	0.0019	CbGeAlD
Vandetanib—ABCC1—cardiac atrium—Behcet's disease	0.00105	0.00189	CbGeAlD
Vandetanib—ORM1—nervous system—Behcet's disease	0.00103	0.00185	CbGeAlD
Vandetanib—ORM1—central nervous system—Behcet's disease	0.000994	0.00178	CbGeAlD
Vandetanib—ABL1—nervous system—Behcet's disease	0.000981	0.00176	CbGeAlD
Vandetanib—MAP2K5—brain—Behcet's disease	0.000972	0.00174	CbGeAlD
Vandetanib—KDR—brain—Behcet's disease	0.000972	0.00174	CbGeAlD
Vandetanib—ABL1—central nervous system—Behcet's disease	0.000944	0.00169	CbGeAlD
Vandetanib—ABCG2—mammalian vulva—Behcet's disease	0.000912	0.00164	CbGeAlD
Vandetanib—PDGFRB—brain—Behcet's disease	0.000841	0.00151	CbGeAlD
Vandetanib—ABCG2—medulla oblongata—Behcet's disease	0.000823	0.00148	CbGeAlD
Vandetanib—ABCG2—midbrain—Behcet's disease	0.000752	0.00135	CbGeAlD
Vandetanib—ABL1—brain—Behcet's disease	0.00075	0.00135	CbGeAlD
Vandetanib—ABCG2—spinal cord—Behcet's disease	0.000734	0.00132	CbGeAlD
Vandetanib—ALB—brain—Behcet's disease	0.000692	0.00124	CbGeAlD
Vandetanib—ABCC1—brain—Behcet's disease	0.000571	0.00102	CbGeAlD
Vandetanib—ABCG2—brain—Behcet's disease	0.000473	0.000848	CbGeAlD
Vandetanib—CYP3A4—nervous system—Behcet's disease	0.000431	0.000773	CbGeAlD
Vandetanib—CYP3A4—central nervous system—Behcet's disease	0.000415	0.000744	CbGeAlD
Vandetanib—PDGFRB—MAPK Signaling Pathway—TNF—Behcet's disease	0.0002	0.000451	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—APOA1—Behcet's disease	0.0002	0.000451	CbGpPWpGaD
Vandetanib—EGFR—Immune System—ITGB2—Behcet's disease	0.000197	0.000444	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—TNF—Behcet's disease	0.000196	0.000443	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—ITGAL—Behcet's disease	0.000195	0.00044	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CTLA4—Behcet's disease	0.000194	0.000438	CbGpPWpGaD
Vandetanib—SRC—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000193	0.000437	CbGpPWpGaD
Vandetanib—YES1—Immune System—CTLA4—Behcet's disease	0.000192	0.000435	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—APOB—Behcet's disease	0.000191	0.000432	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—APOA1—Behcet's disease	0.000191	0.000431	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—SERPINE1—Behcet's disease	0.000191	0.000431	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—ICAM1—Behcet's disease	0.000191	0.000431	CbGpPWpGaD
Vandetanib—LCK—Immune System—ITGB2—Behcet's disease	0.00019	0.000428	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—HLA-B—Behcet's disease	0.000186	0.00042	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—SERPINE1—Behcet's disease	0.000184	0.000416	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—HLA-B—Behcet's disease	0.000184	0.000415	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—APOA1—Behcet's disease	0.000183	0.000412	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—HLA-B—Behcet's disease	0.000182	0.000412	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—NOS3—Behcet's disease	0.000182	0.000411	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—HLA-B—Behcet's disease	0.000181	0.00041	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00018	0.000406	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—HLA-B—Behcet's disease	0.000179	0.000405	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—APOB—Behcet's disease	0.000179	0.000405	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—HLA-B—Behcet's disease	0.000179	0.000404	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—CAT—Behcet's disease	0.000178	0.000401	CbGpPWpGaD
Vandetanib—EGFR—Immune System—ITGAL—Behcet's disease	0.000177	0.000401	CbGpPWpGaD
Vandetanib—BLK—Immune System—HLA-B—Behcet's disease	0.000177	0.0004	CbGpPWpGaD
Vandetanib—FGR—Immune System—HLA-B—Behcet's disease	0.000176	0.000398	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—NOS3—Behcet's disease	0.000176	0.000397	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000176	0.000397	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—HLA-B—Behcet's disease	0.000175	0.000395	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—SERPINE1—Behcet's disease	0.000173	0.000391	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—APOA1—Behcet's disease	0.000173	0.000391	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—APOB—Behcet's disease	0.000172	0.00039	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—APOA1—Behcet's disease	0.000172	0.000389	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—HLA-B—Behcet's disease	0.000172	0.000389	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CTLA4—Behcet's disease	0.000172	0.000388	CbGpPWpGaD
Vandetanib—MKNK1—Disease—SERPINE1—Behcet's disease	0.000172	0.000387	CbGpPWpGaD
Vandetanib—LCK—Immune System—ITGAL—Behcet's disease	0.000171	0.000386	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000171	0.000386	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—APOA1—Behcet's disease	0.00017	0.000385	CbGpPWpGaD
Vandetanib—SRC—Immune System—ITGB2—Behcet's disease	0.000168	0.000379	CbGpPWpGaD
Vandetanib—EGFR—MAPK Signaling Pathway—TNF—Behcet's disease	0.000166	0.000376	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—NOS3—Behcet's disease	0.000165	0.000374	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—ICAM1—Behcet's disease	0.000165	0.000373	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000165	0.000372	CbGpPWpGaD
Vandetanib—MKNK1—Disease—NOS3—Behcet's disease	0.000164	0.00037	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-B—Behcet's disease	0.000162	0.000366	CbGpPWpGaD
Vandetanib—ERBB3—Disease—APOB—Behcet's disease	0.000162	0.000365	CbGpPWpGaD
Vandetanib—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	0.000161	0.000363	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCR1—Behcet's disease	0.000161	0.000363	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—APOB—Behcet's disease	0.000159	0.000359	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—SERPINE1—Behcet's disease	0.000159	0.000358	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCR1—Behcet's disease	0.000157	0.000355	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—HLA-B—Behcet's disease	0.000155	0.00035	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCR1—Behcet's disease	0.000155	0.000349	CbGpPWpGaD
Vandetanib—SRC—Immune System—ITGAL—Behcet's disease	0.000151	0.000342	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—APOA1—Behcet's disease	0.000151	0.000342	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—NOS3—Behcet's disease	0.000151	0.000342	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.00015	0.00034	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.00015	0.000339	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—ICAM1—Behcet's disease	0.000149	0.000338	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—HLA-B—Behcet's disease	0.000149	0.000337	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-B—Behcet's disease	0.000149	0.000336	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—CXCL8—Behcet's disease	0.000147	0.000331	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CTLA4—Behcet's disease	0.000147	0.000331	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—ICAM1—Behcet's disease	0.000145	0.000328	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—SERPINE1—Behcet's disease	0.000145	0.000327	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—NOS3—Behcet's disease	0.000145	0.000327	CbGpPWpGaD
Vandetanib—BLK—Immune System—ICAM1—Behcet's disease	0.000144	0.000325	CbGpPWpGaD
Vandetanib—LYN—Immune System—CTLA4—Behcet's disease	0.000144	0.000324	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-B—Behcet's disease	0.000143	0.000324	CbGpPWpGaD
Vandetanib—FGR—Immune System—ICAM1—Behcet's disease	0.000143	0.000324	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CTLA4—Behcet's disease	0.000143	0.000323	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-B—Behcet's disease	0.000142	0.000322	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000142	0.000321	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—ICAM1—Behcet's disease	0.000142	0.000321	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—APOA1—Behcet's disease	0.000142	0.00032	CbGpPWpGaD
Vandetanib—FYN—Immune System—CTLA4—Behcet's disease	0.000141	0.000319	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—ICAM1—Behcet's disease	0.00014	0.000316	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—NOS3—Behcet's disease	0.000138	0.000313	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—SERPINE1—Behcet's disease	0.000137	0.00031	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—SERPINE1—Behcet's disease	0.000137	0.000309	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—APOA1—Behcet's disease	0.000136	0.000308	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—SERPINE1—Behcet's disease	0.000135	0.000306	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000135	0.000305	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—CXCL8—Behcet's disease	0.000134	0.000303	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR1—Behcet's disease	0.000134	0.000302	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—HLA-B—Behcet's disease	0.000132	0.000299	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—ICAM1—Behcet's disease	0.000132	0.000298	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—NOS3—Behcet's disease	0.000131	0.000296	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000131	0.000295	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—NOS3—Behcet's disease	0.000131	0.000295	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—NOS3—Behcet's disease	0.000129	0.000292	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR1—Behcet's disease	0.000129	0.000291	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—APOB—Behcet's disease	0.000129	0.00029	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000128	0.000289	CbGpPWpGaD
Vandetanib—ERBB3—Disease—APOA1—Behcet's disease	0.000128	0.000289	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—TNF—Behcet's disease	0.000128	0.000288	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-B—Behcet's disease	0.000127	0.000287	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—APOA1—Behcet's disease	0.000126	0.000284	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—CXCL8—Behcet's disease	0.000123	0.000277	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CTLA4—Behcet's disease	0.000122	0.000276	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—ICAM1—Behcet's disease	0.000121	0.000273	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—SERPINE1—Behcet's disease	0.00012	0.000271	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000119	0.000269	CbGpPWpGaD
Vandetanib—LCK—Immune System—CTLA4—Behcet's disease	0.000118	0.000266	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—APOB—Behcet's disease	0.000118	0.000266	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—ICAM1—Behcet's disease	0.000117	0.000263	CbGpPWpGaD
Vandetanib—YES1—Immune System—ICAM1—Behcet's disease	0.000116	0.000261	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—NOS3—Behcet's disease	0.000115	0.000259	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—TNF—Behcet's disease	0.000115	0.000259	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—APOB—Behcet's disease	0.000115	0.000259	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR1—Behcet's disease	0.000114	0.000258	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—APOB—Behcet's disease	0.000113	0.000256	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—SERPINE1—Behcet's disease	0.000113	0.000254	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—TNF—Behcet's disease	0.000111	0.00025	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-B—Behcet's disease	0.000108	0.000245	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—APOB—Behcet's disease	0.000108	0.000244	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—NOS3—Behcet's disease	0.000108	0.000243	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—APOB—Behcet's disease	0.000107	0.000242	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-B—Behcet's disease	0.000106	0.00024	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-B—Behcet's disease	0.000106	0.000239	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-B—Behcet's disease	0.000105	0.000236	CbGpPWpGaD
Vandetanib—FYN—Disease—APOB—Behcet's disease	0.000104	0.000236	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTLA4—Behcet's disease	0.000104	0.000235	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—NOS3—Behcet's disease	0.000103	0.000234	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—ICAM1—Behcet's disease	0.000103	0.000233	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—APOB—Behcet's disease	0.000103	0.000233	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—CXCL8—Behcet's disease	0.000102	0.00023	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—APOA1—Behcet's disease	0.000102	0.00023	CbGpPWpGaD
Vandetanib—ERBB3—Disease—SERPINE1—Behcet's disease	0.000102	0.00023	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—SERPINE1—Behcet's disease	9.97e-05	0.000225	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—APOB—Behcet's disease	9.95e-05	0.000225	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	9.76e-05	0.00022	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NOS3—Behcet's disease	9.7e-05	0.000219	CbGpPWpGaD
Vandetanib—ABCC1—Disease—APOB—Behcet's disease	9.56e-05	0.000216	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—NOS3—Behcet's disease	9.52e-05	0.000215	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—APOA1—Behcet's disease	9.3e-05	0.00021	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	9.28e-05	0.00021	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—APOA1—Behcet's disease	9.07e-05	0.000205	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-B—Behcet's disease	9.03e-05	0.000204	CbGpPWpGaD
Vandetanib—EGFR—Disease—APOB—Behcet's disease	9.01e-05	0.000203	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—APOA1—Behcet's disease	8.97e-05	0.000203	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—ICAM1—Behcet's disease	8.81e-05	0.000199	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-B—Behcet's disease	8.7e-05	0.000197	CbGpPWpGaD
Vandetanib—LCK—Disease—APOB—Behcet's disease	8.68e-05	0.000196	CbGpPWpGaD
Vandetanib—LYN—Immune System—ICAM1—Behcet's disease	8.62e-05	0.000195	CbGpPWpGaD
Vandetanib—ABL1—Immune System—ICAM1—Behcet's disease	8.58e-05	0.000194	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—APOA1—Behcet's disease	8.56e-05	0.000193	CbGpPWpGaD
Vandetanib—FYN—Immune System—ICAM1—Behcet's disease	8.49e-05	0.000192	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—APOA1—Behcet's disease	8.48e-05	0.000192	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TNF—Behcet's disease	8.26e-05	0.000186	CbGpPWpGaD
Vandetanib—FYN—Disease—APOA1—Behcet's disease	8.25e-05	0.000186	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CAT—Behcet's disease	8.25e-05	0.000186	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TNF—Behcet's disease	8.22e-05	0.000186	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—APOA1—Behcet's disease	8.15e-05	0.000184	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TNF—Behcet's disease	8.13e-05	0.000184	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—SERPINE1—Behcet's disease	8.07e-05	0.000182	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOB—Behcet's disease	8.01e-05	0.000181	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—APOA1—Behcet's disease	7.87e-05	0.000178	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	7.72e-05	0.000174	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—NOS3—Behcet's disease	7.71e-05	0.000174	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-B—Behcet's disease	7.7e-05	0.000174	CbGpPWpGaD
Vandetanib—SRC—Disease—APOB—Behcet's disease	7.69e-05	0.000174	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOB—Behcet's disease	7.58e-05	0.000171	CbGpPWpGaD
Vandetanib—ABCC1—Disease—APOA1—Behcet's disease	7.56e-05	0.000171	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOB—Behcet's disease	7.42e-05	0.000168	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—SERPINE1—Behcet's disease	7.38e-05	0.000167	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.34e-05	0.000166	CbGpPWpGaD
Vandetanib—EGFR—Immune System—ICAM1—Behcet's disease	7.34e-05	0.000166	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOB—Behcet's disease	7.3e-05	0.000165	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CAT—Behcet's disease	7.26e-05	0.000164	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—SERPINE1—Behcet's disease	7.2e-05	0.000163	CbGpPWpGaD
Vandetanib—EGFR—Disease—APOA1—Behcet's disease	7.13e-05	0.000161	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—SERPINE1—Behcet's disease	7.12e-05	0.000161	CbGpPWpGaD
Vandetanib—LCK—Immune System—ICAM1—Behcet's disease	7.07e-05	0.00016	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NOS3—Behcet's disease	7.05e-05	0.000159	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOB—Behcet's disease	7.04e-05	0.000159	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TNF—Behcet's disease	7.02e-05	0.000159	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NOS3—Behcet's disease	6.87e-05	0.000155	CbGpPWpGaD
Vandetanib—LCK—Disease—APOA1—Behcet's disease	6.87e-05	0.000155	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CXCL8—Behcet's disease	6.84e-05	0.000154	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NOS3—Behcet's disease	6.8e-05	0.000153	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—SERPINE1—Behcet's disease	6.8e-05	0.000153	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—SERPINE1—Behcet's disease	6.73e-05	0.000152	CbGpPWpGaD
Vandetanib—FYN—Disease—SERPINE1—Behcet's disease	6.55e-05	0.000148	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NOS3—Behcet's disease	6.49e-05	0.000147	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—SERPINE1—Behcet's disease	6.47e-05	0.000146	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—NOS3—Behcet's disease	6.43e-05	0.000145	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOA1—Behcet's disease	6.33e-05	0.000143	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOB—Behcet's disease	6.31e-05	0.000142	CbGpPWpGaD
Vandetanib—SRC—Immune System—ICAM1—Behcet's disease	6.26e-05	0.000141	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CXCL8—Behcet's disease	6.25e-05	0.000141	CbGpPWpGaD
Vandetanib—FYN—Disease—NOS3—Behcet's disease	6.25e-05	0.000141	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—SERPINE1—Behcet's disease	6.25e-05	0.000141	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NOS3—Behcet's disease	6.18e-05	0.000139	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CXCL8—Behcet's disease	6.09e-05	0.000138	CbGpPWpGaD
Vandetanib—SRC—Disease—APOA1—Behcet's disease	6.08e-05	0.000137	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOB—Behcet's disease	6.08e-05	0.000137	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CXCL8—Behcet's disease	6.03e-05	0.000136	CbGpPWpGaD
Vandetanib—ABCC1—Disease—SERPINE1—Behcet's disease	6e-05	0.000136	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOA1—Behcet's disease	5.99e-05	0.000135	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—Behcet's disease	5.99e-05	0.000135	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NOS3—Behcet's disease	5.97e-05	0.000135	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOA1—Behcet's disease	5.87e-05	0.000133	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOA1—Behcet's disease	5.78e-05	0.00013	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NOS3—Behcet's disease	5.73e-05	0.000129	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CXCL8—Behcet's disease	5.68e-05	0.000128	CbGpPWpGaD
Vandetanib—EGFR—Disease—SERPINE1—Behcet's disease	5.66e-05	0.000128	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOA1—Behcet's disease	5.57e-05	0.000126	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CXCL8—Behcet's disease	5.48e-05	0.000124	CbGpPWpGaD
Vandetanib—LCK—Disease—SERPINE1—Behcet's disease	5.45e-05	0.000123	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS3—Behcet's disease	5.4e-05	0.000122	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOB—Behcet's disease	5.38e-05	0.000122	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CXCL8—Behcet's disease	5.29e-05	0.000119	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS3—Behcet's disease	5.21e-05	0.000118	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOA1—Behcet's disease	4.99e-05	0.000113	CbGpPWpGaD
Vandetanib—SRC—Disease—SERPINE1—Behcet's disease	4.83e-05	0.000109	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOA1—Behcet's disease	4.81e-05	0.000109	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NOS3—Behcet's disease	4.8e-05	0.000108	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SERPINE1—Behcet's disease	4.76e-05	0.000107	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SERPINE1—Behcet's disease	4.66e-05	0.000105	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS3—Behcet's disease	4.61e-05	0.000104	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SERPINE1—Behcet's disease	4.59e-05	0.000104	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NOS3—Behcet's disease	4.54e-05	0.000103	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CAT—Behcet's disease	4.48e-05	0.000101	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NOS3—Behcet's disease	4.45e-05	0.0001	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NOS3—Behcet's disease	4.38e-05	9.89e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOB—Behcet's disease	4.35e-05	9.82e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOA1—Behcet's disease	4.26e-05	9.62e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NOS3—Behcet's disease	4.22e-05	9.54e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL8—Behcet's disease	4.03e-05	9.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SERPINE1—Behcet's disease	3.96e-05	8.95e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL8—Behcet's disease	3.95e-05	8.91e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—Behcet's disease	3.88e-05	8.77e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SERPINE1—Behcet's disease	3.82e-05	8.62e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NOS3—Behcet's disease	3.78e-05	8.54e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NOS3—Behcet's disease	3.65e-05	8.23e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOA1—Behcet's disease	3.44e-05	7.77e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SERPINE1—Behcet's disease	3.38e-05	7.63e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—Behcet's disease	3.36e-05	7.58e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—Behcet's disease	3.23e-05	7.3e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NOS3—Behcet's disease	3.23e-05	7.29e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—Behcet's disease	2.86e-05	6.47e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NOS3—Behcet's disease	2.61e-05	5.89e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CAT—Behcet's disease	2.42e-05	5.46e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOB—Behcet's disease	2.35e-05	5.3e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOA1—Behcet's disease	1.86e-05	4.19e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NOS3—Behcet's disease	1.41e-05	3.18e-05	CbGpPWpGaD
